nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoclopramide—DRD3—Parkinson's disease	0.358	0.458	CbGaD
Metoclopramide—DRD2—Parkinson's disease	0.248	0.317	CbGaD
Metoclopramide—CYP2D6—Parkinson's disease	0.175	0.224	CbGaD
Metoclopramide—HTR3A—enteric nervous system—Parkinson's disease	0.0154	0.215	CbGeAlD
Metoclopramide—HTR3A—myenteric nerve plexus—Parkinson's disease	0.0117	0.163	CbGeAlD
Metoclopramide—DRD3—telencephalic ventricle—Parkinson's disease	0.00697	0.0975	CbGeAlD
Metoclopramide—HTR3A—nerve—Parkinson's disease	0.00304	0.0425	CbGeAlD
Metoclopramide—DRD2—telencephalic ventricle—Parkinson's disease	0.00295	0.0412	CbGeAlD
Metoclopramide—CYP11B2—cardiovascular system—Parkinson's disease	0.00222	0.0311	CbGeAlD
Metoclopramide—HTR4—brain—Parkinson's disease	0.00193	0.0271	CbGeAlD
Metoclopramide—DRD2—nerve—Parkinson's disease	0.00186	0.026	CbGeAlD
Metoclopramide—Sunitinib—STK39—Parkinson's disease	0.00141	0.155	CrCbGaD
Metoclopramide—Sunitinib—INSR—Parkinson's disease	0.00141	0.155	CrCbGaD
Metoclopramide—DRD2—hindbrain—Parkinson's disease	0.00139	0.0195	CbGeAlD
Metoclopramide—HTR3A—brainstem—Parkinson's disease	0.0013	0.0182	CbGeAlD
Metoclopramide—HTR3A—forebrain—Parkinson's disease	0.00126	0.0176	CbGeAlD
Metoclopramide—CYP17A1—medulla oblongata—Parkinson's disease	0.00116	0.0162	CbGeAlD
Metoclopramide—DRD3—head—Parkinson's disease	0.00104	0.0146	CbGeAlD
Metoclopramide—DRD3—nervous system—Parkinson's disease	0.000987	0.0138	CbGeAlD
Metoclopramide—CHRM1—forebrain—Parkinson's disease	0.000956	0.0134	CbGeAlD
Metoclopramide—DRD3—central nervous system—Parkinson's disease	0.000951	0.0133	CbGeAlD
Metoclopramide—CYP17A1—head—Parkinson's disease	0.000918	0.0128	CbGeAlD
Metoclopramide—Sunitinib—MERTK—Parkinson's disease	0.000908	0.0999	CrCbGaD
Metoclopramide—CYP17A1—nervous system—Parkinson's disease	0.00087	0.0122	CbGeAlD
Metoclopramide—CYP17A1—central nervous system—Parkinson's disease	0.000838	0.0117	CbGeAlD
Metoclopramide—CYP2D6—hindbrain—Parkinson's disease	0.000836	0.0117	CbGeAlD
Metoclopramide—Bromopride—DRD2—Parkinson's disease	0.000833	0.0916	CrCbGaD
Metoclopramide—Sunitinib—LRRK2—Parkinson's disease	0.000809	0.089	CrCbGaD
Metoclopramide—CHRM1—cardiovascular system—Parkinson's disease	0.000808	0.0113	CbGeAlD
Metoclopramide—DRD2—brainstem—Parkinson's disease	0.000797	0.0112	CbGeAlD
Metoclopramide—DRD2—forebrain—Parkinson's disease	0.00077	0.0108	CbGeAlD
Metoclopramide—DRD3—brain—Parkinson's disease	0.000755	0.0106	CbGeAlD
Metoclopramide—HTR3A—head—Parkinson's disease	0.00072	0.0101	CbGeAlD
Metoclopramide—HTR3A—nervous system—Parkinson's disease	0.000683	0.00956	CbGeAlD
Metoclopramide—Amisulpride—HTR7—Parkinson's disease	0.000672	0.0739	CrCbGaD
Metoclopramide—CYP17A1—brain—Parkinson's disease	0.000665	0.00931	CbGeAlD
Metoclopramide—HTR3A—central nervous system—Parkinson's disease	0.000657	0.0092	CbGeAlD
Metoclopramide—Amisulpride—DRD3—Parkinson's disease	0.000632	0.0695	CrCbGaD
Metoclopramide—CHRM1—head—Parkinson's disease	0.000547	0.00766	CbGeAlD
Metoclopramide—HTR3A—brain—Parkinson's disease	0.000522	0.0073	CbGeAlD
Metoclopramide—CHRM1—nervous system—Parkinson's disease	0.000519	0.00726	CbGeAlD
Metoclopramide—DRD2—midbrain—Parkinson's disease	0.000508	0.00711	CbGeAlD
Metoclopramide—CHRM1—central nervous system—Parkinson's disease	0.000499	0.00699	CbGeAlD
Metoclopramide—CYP2D6—brainstem—Parkinson's disease	0.000479	0.0067	CbGeAlD
Metoclopramide—CYP2D6—forebrain—Parkinson's disease	0.000462	0.00647	CbGeAlD
Metoclopramide—DRD2—head—Parkinson's disease	0.000441	0.00617	CbGeAlD
Metoclopramide—Amisulpride—DRD2—Parkinson's disease	0.000437	0.0481	CrCbGaD
Metoclopramide—DRD2—nervous system—Parkinson's disease	0.000418	0.00585	CbGeAlD
Metoclopramide—Chloroprocaine—SLC6A3—Parkinson's disease	0.000414	0.0456	CrCbGaD
Metoclopramide—DRD2—central nervous system—Parkinson's disease	0.000402	0.00563	CbGeAlD
Metoclopramide—CHRM1—brain—Parkinson's disease	0.000396	0.00555	CbGeAlD
Metoclopramide—Procaine—SLC6A3—Parkinson's disease	0.000395	0.0435	CrCbGaD
Metoclopramide—DRD2—cerebellum—Parkinson's disease	0.000393	0.0055	CbGeAlD
Metoclopramide—Amisulpride—HTR2A—Parkinson's disease	0.000338	0.0372	CrCbGaD
Metoclopramide—DRD2—brain—Parkinson's disease	0.000319	0.00447	CbGeAlD
Metoclopramide—CYP2D6—head—Parkinson's disease	0.000265	0.0037	CbGeAlD
Metoclopramide—Cisapride—DRD2—Parkinson's disease	0.000262	0.0288	CrCbGaD
Metoclopramide—CYP2D6—nervous system—Parkinson's disease	0.000251	0.00351	CbGeAlD
Metoclopramide—CYP2D6—central nervous system—Parkinson's disease	0.000242	0.00338	CbGeAlD
Metoclopramide—CYP2D6—cerebellum—Parkinson's disease	0.000236	0.00331	CbGeAlD
Metoclopramide—Cisapride—HTR2A—Parkinson's disease	0.000202	0.0223	CrCbGaD
Metoclopramide—CYP2D6—brain—Parkinson's disease	0.000192	0.00268	CbGeAlD
Metoclopramide—Cisapride—CYP2D6—Parkinson's disease	0.000185	0.0204	CrCbGaD
Metoclopramide—Procainamide—CYP2D6—Parkinson's disease	0.000108	0.0118	CrCbGaD
Metoclopramide—Sunitinib—ABCB1—Parkinson's disease	7.86e-05	0.00865	CrCbGaD
Metoclopramide—CHRM1—Signaling by GPCR—PENK—Parkinson's disease	4.07e-05	0.000296	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—CTGF—Parkinson's disease	4.03e-05	0.000293	CbGpPWpGaD
Metoclopramide—DRD3—Circadian rythm related genes—MAPK8—Parkinson's disease	4.01e-05	0.000291	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—RIT2—Parkinson's disease	3.98e-05	0.000289	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	3.96e-05	0.000287	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—HTR2A—Parkinson's disease	3.94e-05	0.000286	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—ADORA2A—Parkinson's disease	3.93e-05	0.000286	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—IGF2—Parkinson's disease	3.91e-05	0.000284	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—GRM5—Parkinson's disease	3.9e-05	0.000283	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	3.87e-05	0.000281	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—CYP2D6—Parkinson's disease	3.84e-05	0.000279	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—DGKQ—Parkinson's disease	3.81e-05	0.000277	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—GPR37—Parkinson's disease	3.81e-05	0.000277	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—GRM5—Parkinson's disease	3.81e-05	0.000277	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—PDYN—Parkinson's disease	3.81e-05	0.000276	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—IGF1R—Parkinson's disease	3.78e-05	0.000275	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—GRK5—Parkinson's disease	3.78e-05	0.000274	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—CTGF—Parkinson's disease	3.77e-05	0.000274	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—HTR1A—Parkinson's disease	3.76e-05	0.000273	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—CYP2E1—Parkinson's disease	3.76e-05	0.000273	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—EDN1—Parkinson's disease	3.74e-05	0.000271	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—DGKQ—Parkinson's disease	3.73e-05	0.000271	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—GPR37—Parkinson's disease	3.73e-05	0.000271	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—PDYN—Parkinson's disease	3.72e-05	0.00027	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—NQO1—Parkinson's disease	3.71e-05	0.00027	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—TAC1—Parkinson's disease	3.7e-05	0.000269	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—TH—Parkinson's disease	3.66e-05	0.000266	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—DRD1—Parkinson's disease	3.63e-05	0.000263	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—COMT—Parkinson's disease	3.61e-05	0.000262	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—GSTP1—Parkinson's disease	3.59e-05	0.000261	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—MAOA—Parkinson's disease	3.59e-05	0.00026	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—HMOX1—Parkinson's disease	3.55e-05	0.000257	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—GRM5—Parkinson's disease	3.54e-05	0.000257	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—CYCS—Parkinson's disease	3.51e-05	0.000255	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—CYP2E1—Parkinson's disease	3.51e-05	0.000255	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PPP1R1B—Parkinson's disease	3.49e-05	0.000253	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—NQO1—Parkinson's disease	3.47e-05	0.000252	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—GRM5—Parkinson's disease	3.46e-05	0.000251	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—EDN1—Parkinson's disease	3.44e-05	0.00025	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—NGF—Parkinson's disease	3.43e-05	0.000249	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—TH—Parkinson's disease	3.42e-05	0.000249	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PPP1R1B—Parkinson's disease	3.41e-05	0.000248	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—HTR1A—Parkinson's disease	3.41e-05	0.000248	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—ABCB1—Parkinson's disease	3.4e-05	0.000247	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—GRM4—Parkinson's disease	3.39e-05	0.000246	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—EDN1—Parkinson's disease	3.37e-05	0.000245	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—TAC1—Parkinson's disease	3.36e-05	0.000244	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—ADORA2A—Parkinson's disease	3.31e-05	0.000241	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—GSTM1—Parkinson's disease	3.3e-05	0.00024	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—DRD1—Parkinson's disease	3.29e-05	0.000239	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—CYCS—Parkinson's disease	3.29e-05	0.000239	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—ADRBK1—Parkinson's disease	3.28e-05	0.000238	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—HTR2A—Parkinson's disease	3.27e-05	0.000237	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—ADORA2A—Parkinson's disease	3.24e-05	0.000235	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PENK—Parkinson's disease	3.21e-05	0.000233	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—MAG—Parkinson's disease	3.21e-05	0.000233	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—HTR7—Parkinson's disease	3.18e-05	0.000231	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—DRD2—Parkinson's disease	3.18e-05	0.000231	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—GPX1—Parkinson's disease	3.16e-05	0.00023	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—COMT—Parkinson's disease	3.11e-05	0.000226	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—GSTP1—Parkinson's disease	3.1e-05	0.000225	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—MAOA—Parkinson's disease	3.09e-05	0.000224	CbGpPWpGaD
Metoclopramide—DRD2—Circadian rythm related genes—MAPK8—Parkinson's disease	3.06e-05	0.000223	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—HMOX1—Parkinson's disease	3.05e-05	0.000222	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—RIT2—Parkinson's disease	3.05e-05	0.000221	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—APOE—Parkinson's disease	3.04e-05	0.000221	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—HTR2A—Parkinson's disease	3.01e-05	0.000219	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—ADORA2A—Parkinson's disease	3.01e-05	0.000218	CbGpPWpGaD
Metoclopramide—CHRM1—Circadian rythm related genes—MAPK8—Parkinson's disease	3e-05	0.000218	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—MCCC1—Parkinson's disease	2.99e-05	0.000217	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ND3—Parkinson's disease	2.99e-05	0.000217	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—RIT2—Parkinson's disease	2.98e-05	0.000217	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—ADRBK1—Parkinson's disease	2.98e-05	0.000216	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—HTR2A—Parkinson's disease	2.95e-05	0.000214	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—ADORA2A—Parkinson's disease	2.94e-05	0.000214	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PDYN—Parkinson's disease	2.94e-05	0.000213	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—ABCB1—Parkinson's disease	2.93e-05	0.000213	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—MTHFR—Parkinson's disease	2.92e-05	0.000212	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—COMT—Parkinson's disease	2.91e-05	0.000211	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—GSTP1—Parkinson's disease	2.9e-05	0.00021	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—MAOA—Parkinson's disease	2.89e-05	0.00021	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—GRK5—Parkinson's disease	2.89e-05	0.00021	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—HTR7—Parkinson's disease	2.89e-05	0.00021	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—DRD2—Parkinson's disease	2.89e-05	0.00021	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—HTR1A—Parkinson's disease	2.87e-05	0.000209	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—HMOX1—Parkinson's disease	2.86e-05	0.000208	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—GSTM1—Parkinson's disease	2.85e-05	0.000207	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—TAC1—Parkinson's disease	2.83e-05	0.000206	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—GRK5—Parkinson's disease	2.83e-05	0.000205	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—HTR1A—Parkinson's disease	2.81e-05	0.000204	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—OMD—Parkinson's disease	2.81e-05	0.000204	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—TALDO1—Parkinson's disease	2.81e-05	0.000204	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—DRD1—Parkinson's disease	2.78e-05	0.000202	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—TAC1—Parkinson's disease	2.77e-05	0.000201	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—GFAP—Parkinson's disease	2.76e-05	0.000201	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—ABCB1—Parkinson's disease	2.74e-05	0.000199	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—GRM5—Parkinson's disease	2.73e-05	0.000198	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—GPX1—Parkinson's disease	2.73e-05	0.000198	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—APOE—Parkinson's disease	2.72e-05	0.000197	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—DRD1—Parkinson's disease	2.72e-05	0.000197	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—DRD3—Parkinson's disease	2.69e-05	0.000195	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—GSTM1—Parkinson's disease	2.66e-05	0.000193	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	2.66e-05	0.000193	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—DRD3—Parkinson's disease	2.63e-05	0.000191	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—HTR1A—Parkinson's disease	2.61e-05	0.00019	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—INS—Parkinson's disease	2.6e-05	0.000189	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—GRM4—Parkinson's disease	2.59e-05	0.000188	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—TAC1—Parkinson's disease	2.57e-05	0.000187	CbGpPWpGaD
Metoclopramide—DRD3—Circadian rythm related genes—IL6—Parkinson's disease	2.56e-05	0.000186	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—HTR1A—Parkinson's disease	2.55e-05	0.000186	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—GPX1—Parkinson's disease	2.55e-05	0.000185	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—EDN1—Parkinson's disease	2.54e-05	0.000185	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GCH1—Parkinson's disease	2.54e-05	0.000184	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—GRM4—Parkinson's disease	2.54e-05	0.000184	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—DRD1—Parkinson's disease	2.52e-05	0.000183	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—MTHFR—Parkinson's disease	2.52e-05	0.000183	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—TAC1—Parkinson's disease	2.52e-05	0.000183	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—ADRBK1—Parkinson's disease	2.51e-05	0.000182	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—DRD1—Parkinson's disease	2.47e-05	0.000179	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PENK—Parkinson's disease	2.46e-05	0.000179	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—MAG—Parkinson's disease	2.46e-05	0.000179	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—ADRBK1—Parkinson's disease	2.46e-05	0.000178	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—DRD3—Parkinson's disease	2.44e-05	0.000177	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—HTR7—Parkinson's disease	2.43e-05	0.000177	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PENK—Parkinson's disease	2.41e-05	0.000175	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—MAG—Parkinson's disease	2.41e-05	0.000175	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—FGF20—Parkinson's disease	2.39e-05	0.000174	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—DRD3—Parkinson's disease	2.39e-05	0.000174	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—HTR7—Parkinson's disease	2.38e-05	0.000173	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—DRD2—Parkinson's disease	2.38e-05	0.000173	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—MTHFR—Parkinson's disease	2.35e-05	0.000171	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—APOE—Parkinson's disease	2.34e-05	0.00017	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—ADORA2A—Parkinson's disease	2.32e-05	0.000169	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—INS—Parkinson's disease	2.32e-05	0.000169	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—EDN1—Parkinson's disease	2.31e-05	0.000168	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—ADRBK1—Parkinson's disease	2.28e-05	0.000166	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—FBP1—Parkinson's disease	2.26e-05	0.000164	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GBA—Parkinson's disease	2.26e-05	0.000164	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—DBH—Parkinson's disease	2.26e-05	0.000164	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PDYN—Parkinson's disease	2.25e-05	0.000163	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—ADRBK1—Parkinson's disease	2.23e-05	0.000162	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—HTR2A—Parkinson's disease	2.23e-05	0.000162	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—HTR7—Parkinson's disease	2.21e-05	0.00016	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PDYN—Parkinson's disease	2.2e-05	0.00016	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—APOE—Parkinson's disease	2.19e-05	0.000159	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—HTR7—Parkinson's disease	2.16e-05	0.000157	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—DRD2—Parkinson's disease	2.16e-05	0.000157	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—INSR—Parkinson's disease	2.14e-05	0.000156	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—GFAP—Parkinson's disease	2.11e-05	0.000154	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—GRM5—Parkinson's disease	2.09e-05	0.000152	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—GFAP—Parkinson's disease	2.07e-05	0.00015	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—GRM5—Parkinson's disease	2.05e-05	0.000149	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—FGB—Parkinson's disease	2.03e-05	0.000147	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—HTR2A—Parkinson's disease	2.02e-05	0.000147	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—HTR1A—Parkinson's disease	2.01e-05	0.000146	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—INS—Parkinson's disease	2e-05	0.000145	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—TAC1—Parkinson's disease	1.98e-05	0.000144	CbGpPWpGaD
Metoclopramide—DRD2—Circadian rythm related genes—IL6—Parkinson's disease	1.96e-05	0.000142	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—EDN1—Parkinson's disease	1.95e-05	0.000141	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—DRD1—Parkinson's disease	1.95e-05	0.000141	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—CASP3—Parkinson's disease	1.93e-05	0.00014	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—IL6—Parkinson's disease	1.92e-05	0.000139	CbGpPWpGaD
Metoclopramide—CHRM1—Circadian rythm related genes—IL6—Parkinson's disease	1.92e-05	0.000139	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—EDN1—Parkinson's disease	1.9e-05	0.000138	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—INS—Parkinson's disease	1.87e-05	0.000136	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—FGF20—Parkinson's disease	1.83e-05	0.000133	CbGpPWpGaD
Metoclopramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	1.81e-05	0.000132	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—FGF20—Parkinson's disease	1.79e-05	0.00013	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—ADORA2A—Parkinson's disease	1.78e-05	0.000129	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—MAPK8—Parkinson's disease	1.78e-05	0.000129	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—EDN1—Parkinson's disease	1.77e-05	0.000128	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—ADRBK1—Parkinson's disease	1.76e-05	0.000128	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—ADORA2A—Parkinson's disease	1.74e-05	0.000126	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—EDN1—Parkinson's disease	1.73e-05	0.000126	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—HTR7—Parkinson's disease	1.7e-05	0.000124	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—DRD2—Parkinson's disease	1.7e-05	0.000124	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—HTR2A—Parkinson's disease	1.7e-05	0.000124	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—HTR2A—Parkinson's disease	1.67e-05	0.000121	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—DDC—Parkinson's disease	1.66e-05	0.000121	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—INSR—Parkinson's disease	1.64e-05	0.000119	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—INSR—Parkinson's disease	1.6e-05	0.000117	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GSTA4—Parkinson's disease	1.57e-05	0.000114	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—FGB—Parkinson's disease	1.55e-05	0.000113	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—HTR2A—Parkinson's disease	1.55e-05	0.000112	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HTR1A—Parkinson's disease	1.54e-05	0.000112	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—TAC1—Parkinson's disease	1.52e-05	0.00011	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—FGB—Parkinson's disease	1.52e-05	0.00011	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—HTR2A—Parkinson's disease	1.51e-05	0.00011	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HTR1A—Parkinson's disease	1.51e-05	0.00011	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—DRD1—Parkinson's disease	1.49e-05	0.000108	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TAC1—Parkinson's disease	1.49e-05	0.000108	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—DRD1—Parkinson's disease	1.46e-05	0.000106	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—DRD3—Parkinson's disease	1.44e-05	0.000105	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—IGF2—Parkinson's disease	1.43e-05	0.000104	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	1.41e-05	0.000103	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—DRD3—Parkinson's disease	1.41e-05	0.000103	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—MAOB—Parkinson's disease	1.4e-05	0.000102	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—IGF1R—Parkinson's disease	1.38e-05	0.0001	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—EDN1—Parkinson's disease	1.36e-05	9.91e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—ADRBK1—Parkinson's disease	1.35e-05	9.78e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—ADRBK1—Parkinson's disease	1.32e-05	9.57e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HTR7—Parkinson's disease	1.3e-05	9.47e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—DRD2—Parkinson's disease	1.28e-05	9.27e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HTR7—Parkinson's disease	1.28e-05	9.27e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—NGF—Parkinson's disease	1.25e-05	9.11e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—HTR2A—Parkinson's disease	1.19e-05	8.67e-05	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—IL6—Parkinson's disease	1.13e-05	8.24e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—APOE—Parkinson's disease	1.11e-05	8.06e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—IGF2—Parkinson's disease	1.09e-05	7.94e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—IGF2—Parkinson's disease	1.07e-05	7.77e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—IGF1R—Parkinson's disease	1.06e-05	7.67e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—EDN1—Parkinson's disease	1.04e-05	7.58e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—IGF1R—Parkinson's disease	1.03e-05	7.51e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—EDN1—Parkinson's disease	1.02e-05	7.42e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CTGF—Parkinson's disease	1.02e-05	7.41e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NGF—Parkinson's disease	9.6e-06	6.97e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	9.5e-06	6.9e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—INS—Parkinson's disease	9.48e-06	6.89e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—NQO1—Parkinson's disease	9.39e-06	6.82e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NGF—Parkinson's disease	9.39e-06	6.82e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—TH—Parkinson's disease	9.26e-06	6.72e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HTR2A—Parkinson's disease	9.13e-06	6.63e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HTR2A—Parkinson's disease	8.94e-06	6.49e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CYCS—Parkinson's disease	8.89e-06	6.46e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—APOE—Parkinson's disease	8.49e-06	6.17e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—APOE—Parkinson's disease	8.31e-06	6.04e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—COMT—Parkinson's disease	7.87e-06	5.72e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GSTP1—Parkinson's disease	7.84e-06	5.69e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—MAOA—Parkinson's disease	7.82e-06	5.68e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—HMOX1—Parkinson's disease	7.73e-06	5.61e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ABCB1—Parkinson's disease	7.42e-06	5.39e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—INS—Parkinson's disease	7.25e-06	5.27e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GSTM1—Parkinson's disease	7.2e-06	5.23e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—INS—Parkinson's disease	7.1e-06	5.16e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CASP3—Parkinson's disease	7.06e-06	5.13e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—IL6—Parkinson's disease	7.01e-06	5.09e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GPX1—Parkinson's disease	6.9e-06	5.01e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—MAPK8—Parkinson's disease	6.49e-06	4.71e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—MTHFR—Parkinson's disease	6.36e-06	4.62e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—APOE—Parkinson's disease	5.92e-06	4.3e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CASP3—Parkinson's disease	5.4e-06	3.92e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—IL6—Parkinson's disease	5.37e-06	3.9e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CASP3—Parkinson's disease	5.29e-06	3.84e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—IL6—Parkinson's disease	5.25e-06	3.81e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—INS—Parkinson's disease	5.06e-06	3.68e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—MAPK8—Parkinson's disease	4.96e-06	3.61e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—MAPK8—Parkinson's disease	4.86e-06	3.53e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—IL6—Parkinson's disease	4.14e-06	3.01e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—IL6—Parkinson's disease	3.17e-06	2.3e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—IL6—Parkinson's disease	3.1e-06	2.25e-05	CbGpPWpGaD
